A narrative review of hydrogen-oxygen mixture for medical purpose and the inhaler thereof.
Hsin-Yung Lin, Pei-Chen Lai, Wei-Lin Chen · Medical gas research · 2020
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
This narrative review examined the available molecular-hydrogen literature. It is found that inhalation of H₂ (~66%) and O₂ (~34%) significantly improves disease severity of patients with COVID-19, such as improvement of chest distress, chest pain, resting oxygen saturation, and dyspnea scale, etc. The reviewed evidence adds support for molecular hydrogen's therapeutic potential across the conditions, mechanisms, or outcomes examined.
What the Findings Mean
H2HUBB reviewed this publication as a synthesis of molecular-hydrogen research and summarizes the outcomes emphasized by the authors. It is found that inhalation of H₂ (~66%) and O₂ (~34%) significantly improves disease severity of patients with COVID-19, such as improvement of chest distress, chest pain, resting oxygen saturation, and dyspnea scale, etc.
What the Researchers Studied
The authors reviewed a narrative review of hydrogen-oxygen mixture for medical purpose and the inhaler thereof.
What Effects Did Molecular Hydrogen Have?
Source-reported hydrogen concentration: 66% source-reported H₂ gas concentration; Source-reported hydrogen exposure: 66% source-reported H₂ gas concentration. It is found that inhalation of H₂ (~66%) and O₂ (~34%) significantly improves disease severity of patients with COVID-19, such as improvement of chest distress, chest pain, resting oxygen saturation, and dyspnea scale, etc. The authors concluded that hydrogen-oxygen mixture (approximately 66% H₂: 34% O₂ ) for medical purpose is an oncoming and developing research topic. With the installation of the liquid blocking module and flame arresters, the air pathway of the hydrogen inhaler is divided by multiple isolation zones to prevent any unexpected explosion propagating from one zone to the other.
Why These Findings Matter
The reviewed evidence adds support for molecular hydrogen's therapeutic potential across the conditions, mechanisms, or outcomes examined.
How Strong Is This Evidence?
This is review or synthesis evidence (narrative review).
Technical Study Details
H2HUBB classifies this publication as narrative review with review or synthesis evidence. The study used a narrative review. The hydrogen delivery method was inhaled hydrogen gas. The source-reported hydrogen concentration was 66% source-reported H₂ gas concentration.
Limitations and Safety
No separate limitations or safety findings were identified in the source text available to H2HUBB.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.